Reexpression of reduced VEGF activity in liver metastases of experimental pancreatic cancer

Journal of Nippon Medical School

Volumn 72, Issue 3, 2005, Pages 155-164

  Fukuhara, Munehisa ^a,b   Uchida, Eiji ^a   Tajiri, Takashi ^a   Aimoto, Takayuki ^a   Naito, Zenya ^a   Ishiwata, Toshiyuki ^a  

^a NIPPON MEDICAL SCHOOL GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

Experimental pancreatic cancer; Liver metastasis; Pancreatic cancer cell line (PGHAM 1); Vascular endothelial growth factor (VEGF)

Indexed keywords

BIS(2 OXOPROPYL)NITROSAMINE; MESSENGER RNA; VASCULOTROPIN; VASCULOTROPIN A;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CANCER MODEL; CANCER TRANSPLANTATION; FEMALE; GENE EXPRESSION; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; LIVER METASTASIS; NONHUMAN; PANCREAS CANCER; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SILVER STAINING; SYRIAN HAMSTER; ANIMAL; DISEASE MODEL; GENE EXPRESSION REGULATION; GENETICS; HAMSTER; LIVER TUMOR; METASTASIS; PANCREAS TUMOR; PATHOLOGY; PHYSIOLOGY;

ANIMALS; CRICETINAE; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; LIVER NEOPLASMS; MESOCRICETUS; NEOPLASM TRANSPLANTATION; PANCREATIC NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 21744439935     PISSN: 13454676     EISSN: None     Source Type: Journal    
DOI: 10.1272/jnms.72.155     Document Type: Article

References (32)

1. Livingston EH, Welton ML, Reber HA: Surgical treatment of pancreatic cancer. The United States experience. Int J Pancreatol 1991; 9: 153-157.
2. Tominaga S, Oshima A: Cancer mortality and morbidity statistics Japan and the World-1999. Gann Monogr Cancer Res 1999; 47: 217
3. Yeo C J, Abrams RA, Gtochow LB, Sohn TA, Ord SE, Huban RH, Zahurak ML, Doolay WC, Coleman J, Sauter PK, Pitt HA, Littlemoe KD, Cameron JL: Pancreaticoduodenectomy for pancreatic adenocarcinoma: postoperative adjuvant chemoradiation improves survival. Ann Surg 1997; 225: 621-636.
4. Kayahara M, Nagakawa T, Ueno K, Ohta T, Takeda T, Miyazaki I: An evaluation of radical resection for pancreatic cancer based on the mode of recurrence as determined by autopsy and diagnostic imaging. Cancer 1993; 72: 2118-2123.
5. Blood CH, Zetter BR: Tumor interactions with the vasculature: angiogenesis and tumor metastasis. Biochim Biophys Acta 1990; 1032: 89-118.
6. Seo Y, Baba H, Fukuda T, Takashima M, Sugimachi K: High expression of vascular endothelial growth factor is associated with liver metastasis and a poor prognosis for patients with ductal pancreatic adenocarcinoma. Cancer 2000; 88: 2239-2245.
7. Ishigami S, Arii S, Furutani M, Niwano M, Harada T, Mizumoto M, Mori A, Onodera H, Imamura M: Predictive value of vascular endothelial growth factor (VEGF) in metastasis and prognosis of human colorectal cancer. Br J Cancer 1998; 78: 1379-1384.
8. Ishigami S, Arii S, Harada T, Mizumoto M, Mori A, Hanaki K, Takeda Y, Onodera H, Imamura M: The different expression of metastasis related molecules in the primary and metastatic tumors of human colorectal cancer - Interrelationship between cancer cells and stromal tissues-. Jpn J Gustro enterological Surg 1998; 31: 984-989. (in Japanese with English abstract)
9. Berney C, Yang JL, Fisher RJ, Russell PJ, Crowe PJ: Vascular endothelial growth factor expression is reduced in liver metastasis from colorectal cancer and correlates with urokinase-type plasminogen activator. Anticancer Res 1998; 18: 973-978.
10. Yokoyama T, Onda M, Uchida E: Rapid formation of pancreatic tumors by intrapancreatic transplantation of a newly established hamster carcinoma cell line (PGHAM-1) and its sequential analysis. J Jpn Pane Soc 1996:11:411-420. (in Japanese with English abstract)
11. Inoue M, Onda M, Uchida E: The significance of blood group-related antigen A in a pancreatic cell line (PGHAM-1) in hamsters. With special reference to cell proliferation. J Nippon Med Sch 1997; 64: 30-38.
12. Yanagi K, Onda M, Uchida E: Effect of Angiostatin on liver metastasis of pancreatic cancer in hamsters. Jpn J Cancer Res 2000; 91: 723-730.
13. Matsushita A, Onda M, Uchida E, Maekawa R, Yoshioka T: Antitumor effect of a new selective matrix metalloproteinase inhibitor, MMI-166, on experimental pancreatic cancer. Int J Cancer 2001; 92: 434-440.
14. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-159.
15. Ploton D, Menager M, Jeannesson P, Himber G, Pigeon F, Adnet JJ: Improvement in the staining and in the visualization of the argyrophilic proteins of the nucleolar organizer region at the optical level. Histochem J 1986; 18: 5-14.
16. Howat AJ, Giri DD, Cotton DWK, Slater DN: Nucleolar organizer regions in spitz nevi and malignant melanomas. Cancer 1989; 63: 474-478.
17. NOR-a new method for the pathologist (Editorial). Lancet 1987; 1: 1413.
18. Aimoto T, Onda M, Uchida E, Asano G: Study on proliferating potential by Ag-NORs staining in human pancreatic carcinoma. Jpn J Surg Soc 1993; 94: 78-85. (in Japanese with English abstract)
19. Ferrara N, Davis-Smyth T: The biology of vascular endothelial growth factor. Endocr Rev 1997; 18: 4-25.
20. Leung DW, Cachianes G, Kuang WJ, Goedel DV, Ferrara N: Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 1989; 246: 1306.
21. Connolly DT, Heuvelman DM, Nelson R, Olander JV, Eppley BL, Delfino JJ, Siegel NR, Leimgruber RM, Feder J: Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. J Clin Invest 1989; 84: 1470-1478.
22. Folkman J: Anti-angiogenesis: new concept for therapy of solid tumor. Ann Surg 1972; 175: 409-446.
23. Maeda K, Chung Y, Ogawa Y, Takatsuka S, Kang S, Ogawa M, Sawada T, Sowa M: Prognostic value of vascular endothelial growth factor expression in gastric carcinoma. Cancer 1996; 77: 858-863.
24. Warren RS, Yuan H, Matli MR, Gillett NA, Ferrara N: Regulation by vascular endothelial growth factor of human colon cancer tumorigenesis in a mouse model of experimental liver metastasis. J Clin Invest 1995; 95: 1789-1797.
25. Bruns CJ, Liu W, Davis WD, Raymond MS, McConkey DJ, Wilson MR, Bucana CD, Hicklin DJ, Ellis LM: Vascular endothelial growth factor is an in vivo survival factor for tumor endothelium in a murine model of colorectal carcinoma liver metastasis. Cancer 2000; 89: 488-499.
26. Pour PM, Kruger FW, Althoff J, Cardesa A, Mohr U: Cancer of the pancreas in Syrian golden hamster. Am J Pathol 1974; 76: 349-358.
27. Pour PM, Runge RG, Birt D, Gingell R, Lawson T: Current Knowledge of pancreatic carcinogenesis in the hamster and its relevance to the human disease. Cancer 1981; 47: 1573-1589.
28. Naito Z, Ishiwata T, Kurban G, Teduka K, Kawamoto Y, Kawahara K, Sugisaki Y: Expression and accumulation of lumican protein in uterine cervical cancer cells at the periphery of cancer nests. Int J Oncol 2002; 20: 943-948.
29. Novak RF, Woodcroft KJ: The alcohol-inducible form of cytochrome P450 (CYP2E1):role in toxicology and regulation of expression. Arch Pharma Res 2000; 23: 267-282.
30. Shweiki D, Itin A, Soffer D, Keshet E: Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-induced angiogenesis. Nature 1992; 359: 843-845.
31. Ohta T: An experimental study of biological variation among primary and metastatic tumors xenotransplanted into nude mice. Kanazawa Juzen Med Soc 1990; 99: 385-394. (in Japanese with English abstract)
32. Takahashi Y, Minami S, Mai M: The comparative study of biological behavior between primary lesion and metastatic lymph node of gastric cancel-Immunohistochemical study of CEA and CA19-9. Jpn J Cancer Chemother 1986; 13: 2233-2234. (in Japanese with English abstract)